Motor neuron disease beginning with frontotemporal dementia: clinical features and progression

References

• Devenney EM, Ahmed RM, Hodges JR. Frontotemporal dementia. In: Aminoff MJ, Boller F, Swaab DF, eds. Handbook of clinical neurology. 1st ed., Vol. 167. Amsterdam: Elsevier B.V.; 2019:279–99.
   Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al., ITALSGEN Consortium. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011 Oct;72:257–68.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor Neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582–94.
   PubMed Web of Science ®Google Scholar
• Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother. 2015;15:509–22.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
   PubMed Web of Science ®Google Scholar
• Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 2019;93:e984–e994.
   PubMed Web of Science ®Google Scholar
• De Vries BS, Rustemeijer LMM, Bakker LA, Schröder CD, Veldink JH, Van Den Berg LH, et al. Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry. 2019;90:141–7.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077–9. Available from: https://pubmed.ncbi.nlm.nih.gov/12370467
   PubMed Web of Science ®Google Scholar
• Van Langenhove T, Piguet O, Burrell JR, Leyton C, Foxe D, Abela M, et al. Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia. Jad. 2017;58:163–170. May163. 70. Available from: https://doi.org/https://doi.org/10.3233/JAD-161272
   Web of Science ®Google Scholar
• Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral Features in Frontotemporal Dementia With Amyotrophic Lateral Sclerosis. Arch Neurol. 2010;67:826–30. Jul 1 Available from: https://doi.org/https://doi.org/10.1001/archneurol.2010.146
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Dickson DW. Frontotemporal lobar degeneration with upper motor neuron disease/ primary lateral sclerosis . Neurology 2007;69:1800–1.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum. J Neurol. 2018;265:1819–28.
   PubMed Web of Science ®Google Scholar
• de Vries BS, Spreij LA, Rustemeijer LMM, Bakker LA, Veldink JH, van den Berg LH, et al. A neuropsychological and behavioral study of PLS. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:376–84.
   PubMed Web of Science ®Google Scholar
• De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuźma-Kozakiewicz M, et al. International Survey of ALS Experts about critical questions for assessing patients with ALS. Amyotroph Lateral Scler Front Degener. 2017;18:505–10.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, et al. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet. 2014;51:419–24.
   PubMed Web of Science ®Google Scholar
• Altman DG, Bland JM. Statistics notes: time to event (survival) data. BMJ. 1998;317:468–9.
   PubMed Web of Science ®Google Scholar
• Gromicho M, Coutinho AM, Pronto-Laborinho AC, Raposeiro R, Tavares J, Antunes D, et al. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE. J Neurol. 2020;267:3578–92.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al., ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
   PubMed Web of Science ®Google Scholar
• Bersano E, Sarnelli MF, Solara V, Iazzolino B, Peotta L, De MF, et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Front Degener. 2020;21:373–9.
   PubMed Web of Science ®Google Scholar
• Cerami C, Marcone A, Crespi C, Iannaccone S, Marangoni C, Dodich A, et al. Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: a clinical and neurophysiological study. J Neurol Sci. 2015;351:72–7.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AMT, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135:693–708.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919–31.
   PubMed Web of Science ®Google Scholar
• Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012;13:493–501.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Harris J, Richardson A, Rollinson S, Thompson JC, Neary D, et al. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:172–6.
   PubMed Web of Science ®Google Scholar
• Hu WT, Seelaar H, Josephs KA, Knopman DS, Boeve BF, Sorenson EJ, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol. 2009;66:1359–64.
   PubMedGoogle Scholar
• Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology 2011 May 31;76:1886–92.
   PubMed Web of Science ®Google Scholar
• Toyoshima Y, Tan C-F, Kozakai T, Tanaka M, Takahashi H. Is motor neuron disease-inclusion dementia a forme fruste of amyotrophic lateral sclerosis with dementia? An autopsy case further supporting the disease concept. Neuropathology. 2005;25:214–9.
   PubMed Web of Science ®Google Scholar
• Cruts M, Gijselinck I, Van Langenhove T, van der Zee J, Van Broeckhoven C. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci. 2013;36:450–9.
   PubMed Web of Science ®Google Scholar
• Gromicho M, Pinto S, Gisca E, Pronto-Laborinho AC, Andersen PM, de Carvalho M. Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2018;70:325.e7–e15.
   Web of Science ®Google Scholar
• Burke T, Pinto-Grau M, Lonergan K, Bede P, O’Sullivan M, Heverin M, et al. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017 May;4:305–17.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC. Phenotypic variability in ALS-FTD and effect on survival. Neurology 2020;94:e2005–e2013.
   PubMed Web of Science ®Google Scholar
• Gorges M, Del Tredici K, Dreyhaupt J, Braak H, Ludolph AC, Müller H-P, et al. Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data. Sci Rep. 2018;8:15389.
   PubMed Web of Science ®Google Scholar
• Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma‐Kozakiewicz M, Pinto S, et al. Spreading in ALS: the relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol. 2020;7:1181–1192.
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Emilian S, Dreyhaupt J, Rosenbohm A, Kraskov A, Lemon RN, et al. Pattern of paresis in ALS is consistent with the physiology of the corticomotoneuronal projections to different muscle groups. J Neurol Neurosurg Psychiatry. 2020;91:991–8.
   PubMed Web of Science ®Google Scholar
• Pita Lobo P, Pinto S, Rocha L, Reimão S, De Carvalho M. Orofacial apraxia in motor neuron disease. Case Rep Neurol. 2013;5:47–51.
   PubMedGoogle Scholar
• Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590–7.
   PubMed Web of Science ®Google Scholar